Translating cGMP analogues into a treatment for retinitis pigmentosa
Bidragets beskrivning
Inherited retinal degenerations, such as retinitis pigmentosa, cause loss of vision already at young age, because there is no cure to these diseases. In this project, new medication is being developed for the treatment of retinitis pigmentosa. The project aims to generate pre-clinical data that supports translation of the new medications to clinical studies. The role of University of Eastern Finland in this European project is related to formulation of the new compounds in nanostructures to reach targeted and prolonged drug activity.
Visa merStartår
2021
Slutår
2024
Beviljade finansiering
Finansiär
Finlands Akademi
Typ av finansiering
Kansainvälinen yhteisrahoitteinen ohjelma
Övriga uppgifter
Finansieringsbeslutets nummer
344718
Vetenskapsområden
Biomedicinska vetenskaper
Forskningsområden
Biolääketieteet
Identifierade teman
eyes, eye diseases